person

Martin F.

Country
Germany
Department
Pneumologie im Thoraxzentrum Südwest

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
466
Sites with multiple studies

Has run more than one trial at 466 of 709 partner sites.

Specializations

Lung Cancer Treatment

The investigator specializes in advanced therapeutic approaches for non-small cell lung cancer (NSCLC), with particular focus on resectable Stage II and Stage III disease.

  • Early-stage NSCLC management
  • Surgical oncology integration
  • Nodal involvement assessment

Their work encompasses comprehensive treatment strategies for patients with resectable lung malignancies.

Immunotherapy Applications

The investigator focuses on innovative immunotherapeutic approaches in lung cancer treatment, particularly utilizing pembrolizumab-based therapy combinations.

  • Combination immunotherapy protocols
  • Perioperative treatment strategies
  • Novel therapeutic combinations

Their expertise extends to integrating immunotherapy in multimodal treatment approaches.

Treatment Outcomes

The investigator evaluates critical outcome measures in lung cancer therapeutic interventions, focusing on disease-free survival and event-free survival.

  • Survival metrics assessment
  • Treatment response evaluation
  • Long-term outcome analysis

Their research emphasizes comprehensive evaluation of therapeutic efficacy in lung cancer treatment.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.